Viralytics Ltd (VLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
24 Pages - GLDATA58310
$250.00

Summary

Viralytics Ltd (Viralytics), formerly Psiron Limited is a biotechnology company that develops oncology products. The company develops and markets oncolytic immunotherapies for the treatment of different types of cancers. It offers cavataktm, a proprietary formulation for the common cold Coxsackievirus Type A21 (CVA21), is being evaluated in phase 1 and 2 clinical trials. Viralytics’ cavataktm is an oncolytic common cold virus that has demonstrated anti-tumor activity, by following a process called lysis. The company’s products are evaluated both as an intratumoural and intravenous agent in melanoma, prostate, lung and bladder cancers. It conducts research and development through medical research institutes and research facilities in Newcastle, Australia. Viralytics is headquartered in Sydney, New South Wales, Australia.

Viralytics Ltd (VLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Viralytics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Viralytics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Viralytics Enters into Agreement with Merck 10
Equity Offering 11
Viralytics Raises USD3 Million in Share Purchase Plan 11
Viralytics Raises USD20.8 Million in Private Placement of Shares 13
Viralytics Completes Second Tranche Of Private Placement Of Shares For US$20.2Million 15
Viralytics Completes Rights Offering Of Shares For US$3.6 Million 17
Viralytics Completes Private Placement Of US$1.38 Million 19
Viralytics Ltd - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Viralytics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Viralytics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Viralytics Ltd, Deals By Therapy Area, 2010 to YTD 2016 8
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Viralytics Enters into Agreement with Merck 10
Viralytics Raises USD3 Million in Share Purchase Plan 11
Viralytics Raises USD20.8 Million in Private Placement of Shares 13
Viralytics Completes Second Tranche Of Private Placement Of Shares For US$20.2Million 15
Viralytics Completes Rights Offering Of Shares For US$3.6 Million 17
Viralytics Completes Private Placement Of US$1.38 Million 19
Viralytics Ltd, Key Competitors 21
Viralytics Ltd, Key Employees 22
Viralytics Ltd, Other Locations 23

List of Figures
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838